Weihao Li

5PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 05, 2026
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation.

Weihao Li, Jianhong Peng, Jiahua He

|Aug 27, 2025
β-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1.

Jin Lan, Weili Zhang, Kaixuan Zeng

|Jun 30, 2025
circNRIP1 impairs tumorigenesis of colorectal cancer by sponging IGF2BP1 and decreasing NACC1 mRNA stability.

Kai Han, Qiaoqi Sui, Yanbo Xu

|Jun 19, 2024
Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer.

Jianhong Peng, Weili Zhang, Jiahua He

|Aug 24, 2023
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.

Weihao Li, Chi Zhou, Long Yu

Pageof 1

Frequent Collaborators

3 joint publications

Jianhong Peng

3 joint publications

Weili Zhang

2 joint publications

Xiaojun Wu

1 joint publications

Jiahua He